COMPANY

Kazia Therapeutics Limited

HQ: Sydney, Australia source

Profile checked Oct 10, 2026

Funding and NIH signals

SEC Form D raise Form D reports $55.25M, incl. warrant exercise value (filed Dec 18, 2025). SEC Form D 0001470831-25-000435 (Dec 18, 2025)
Evidence (1 event)
- Dec 18, 2025 · SEC Form D 0001470831-25-000435
  Name of Issuer: KAZIA THERAPEUTICS LTD; CIK: 1075880; Address: Sydney Nsw, Australia; Submission type: D; Filing date: 2025-12-18; Industry Group: Biotechnology; Date of First Sale: 2025-12-03; Types of Securities Offered: Equity, Option/warrant, Security to be acquired; Business combination transaction: false; Total Offering Amount: 55251088; Total Amount Sold: 55251088; Federal exemptions: 06b

Job counts as of Oct 18, 2026. All funding and NIH signals